BrainGate™ is working to create advancements in technology that allows severely disabled individuals—including those with traumatic spinal cord injury and loss of limbs—to communicate and control common every day functions, literally through thought.  BrainGate™ Company’s technology as well as other similar technologies are currently undergoing clinical trials at various academic and research institutes, as well as hospitals throughout the United States and Europe.

While BrainGate, Co. does not perform the surgery or actual clinical trials, through Cyberkinetics, leading Universities, and hospitals, the our intellectual property has been used in a number of patients through an FDA approved clinical trial.  Below is a list of clinical trials associated with BrainGate™, as well as those being developed throughout the larger community of Brain-Computer Interfaces:





BrainGate2: Brown University, Mass General Hospital, and the Veterans association (Massachusetts)


Neural Signals: Dr. Philip R. Kennedy (Georgia)

hippocampus mapping



Neural-Prosthesis: Dr. Theodore Berger, University of Southern California (California)




University of Tubingen: Dr. Niels Birbaumer (Germany)


Caltech Pine Lab: Dr. Jerry Pine (California)

DSO logo



US Defense Science Office: Dr. Geoffrey Ling (United States)


Wadsworth Center, New York State Department of Health (New York)


Johns Hopkins University Neuroengineering Lab (Maryland)


Nicolelis Lab, Duke University (North Carolina)

In The News
BrainGate Videos
BrainGate Science
BrainGate Technology
Our company's core BrainGate™ technology is available through engineering and manufacturing partners:
Bionic®, Neural array microchips used in our core technology.
NeuroPort® system for human clinical trials.
Cerebus® system used for research and testing.
Contact us for more information and pricing
© 2009 BrainGate ™, Company  
press room trademarks
contact us terms of use
site map privacy